Skip to main content

Ammonia N-13

Generic: ammonia n-13

Unverified·never
Manufacturer
NCM USA, LLC
Route
INTRAVENOUS
ICD-10 indication
I25.9

Affordability Check

How much will you actually pay for Ammonia N-13?

In 30 seconds, see every legitimate way to afford Ammonia N-13 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Ammonia N-13

What is this medication? Ammonia N-13 is a radioactive diagnostic agent used during a positron emission tomography scan, which is a specialized type of medical imaging. This medication is administered through an intravenous injection to help physicians visualize the flow of blood through the heart muscle, a process known as myocardial perfusion. By emitting positrons that are detected by the imaging equipment, Ammonia N-13 provides a clear map of how effectively oxygen-rich blood is reaching different parts of the cardiac system. Healthcare providers primarily use this agent to evaluate patients who have or are suspected of having coronary artery disease. The resulting images allow doctors to identify specific areas of the heart where blood flow may be restricted or blocked, helping them determine the severity of heart disease. This information is essential for making decisions regarding treatments such as angioplasty or bypass surgery and for assessing the overall health and function of the heart muscle.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Ammonia N-13. Official source: DailyMed (NLM) · Label effective Jan 27, 2026

Adverse reactions
6 ADVERSE REACTIONS No adverse reactions have been reported for Ammonia N 13 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems. However, the completeness of these sources is not known. No adverse reactions have been reported for Ammonia N 13 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system (6) . To report SUSPECTED ADVERSE REACTIONS, contact Kreitchman PET Center at 212-305-0081 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.